Physicians can use peak expiratory flow as a first-line tool for assessing variable airflow limitations among patients with ...

Scientists have identified molecules from blood and urine that may reveal how much energy a person consumes from ...

Two doses of 52-week nerandomilast, a phosphodiesterase 4B inhibitor, lowered FVC decline vs. placebo in patients with ...